Phil Tufnell: 'I don’t know if I’ll ever be able to give up smoking'
THE cricketer turned commentator talks to Busola Evans about cigarettes, his hair transplant and why he hasn ’t ruled out having Botox.
Authors: Kallam A, Armitage JO Abstract INTRODUCTION: T cell lymphomas are a heterogeneous group, with varying incidences, geographic patterns, and risk factors. Although until recently approached in a manner similar to B cell lymphomas, the treatment outcomes are poor and this disease is characterized by high relapse rates. The treatment advances in PTCL have been slow compared to B cell lymphomas. The outcomes of patients who progress following stem cell transplantation are worse. AREAS COVERED: This review focuses on the novel targeted agents that are approved and/or are under investigation for patients with...
In conclusion, despite an early improvement in renal function after everolimus introduction, we found no evidence that everolimus halts the long-term mGFR decline compared to continued low-dose CNI therapy. Due to retrospective design, small sample size and heterogenous characteristics, definite conclusions require prospective studies. PMID: 32479116 [PubMed - as supplied by publisher]
The Model for End-stage Liver Disease (MELD) organ allocation system has led to sex disparities, with women less likely to receive a deceased donor liver transplant (DDLT) and more likely to die on the waiting list, researchers say.Reuters Health Information
Post-transplant lymphoproliferative disease is a well-known complication in transplant recipients. Evaluating the extent and stage of disease is important for management and follow-up. As a combination of anatomic and functional imaging, PET/CT is a sensitive and specific tool to stage and detect occult disease compared with conventional imaging. PET/CT also has a role in monitoring treatment response. Although PET/CT has been shown to be potentially useful in adults, evidence in children is insufficient. This review provides an overview of the use of PET/CT in post-transplant lymphoproliferative disease, especially in pediatric patients.
Conditions: Hematologic Diseases; Stem Cell Transplant Complications; Cytomegalovirus Viremia; Herpesvirus Infection Intervention: Sponsors: Gruppo Italiano Trapianto di Midollo Osseo; Azienda Policlinico Umberto I Not yet recruiting
Conditions: Hepatocellular Carcinoma; Liver Transplant Disorder Intervention: Procedure: Liver transplantation Sponsor: Inonu University Completed
Heart transplant patients are a vulnerable population. A new study suggests a high risk for death if these patients contract COVID-19, pointing to the need for increased precautions and vigilance.Medscape Medical News
(European Society for Blood and Marrow Transplantation) The European Society for Blood and Marrow Transplantation (EBMT) announces a new collaboration with Kite, a Gilead Company, to study the long-term outcomes of patients treated with Yescarta ® (axicabtagene ciloleucel), a chimeric antigen receptor T cell (CAR T) therapy. Under the terms of the collaboration, EBMT will collect treatment and long-term safety and efficacy data for 20 years from patients treated with Yescarta ® in the EBMT registry for cellular therapy.
Abstract Professor Andrew John Lees, from the National Hospital for Neurology and Neurosurgery, a neurological hospital in Queen Square, London, UK, has contributed in a stupendous way to the development of the field of movement disorders in Brazil, with a constant and intense participation in numerous congresses and scientific meetings of this specialty since 1983.Resumo O professor Andrew Lees, do National Hospital for Neurology and Neurosurgery, Queen Square, Londres, Reino Unido, tem contribu ído de maneira estupenda para o desenvolvimento da área dos distúrbios do movimento no Brasil, com uma part...
Publication date: Available online 31 May 2020Source: Pharmacological ResearchAuthor(s): Monica Gulati, Sachin Kumar Singh, Leander Corrie, Indu Pal Kaur, Lipika Chandwani